133 results on '"Wehkamp U"'
Search Results
2. Therapie seltener kutaner T‑Zell-Lymphome und der blastären plasmazytoiden dendritischen Zellneoplasie
3. 179 Oxidative Damage is a Hallmark of Atopic Dermatitis in Humans and Mice
4. Update on the development of EORTC/CLTF questionnaires to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I
5. Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study
6. Dimethyl fumarate (DMF) therapy in CTCL: final results from a clinical phase II study
7. Digitale Bestimmung der vertikalen Tumordicke bei Patienten mit kutanem T-Zell-Lymphom und Korrelation mit klinischen Parametern
8. Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop*
9. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*
10. Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab.
11. PD-1- und PD-L1-Expression beim Merkelzellkarzinom
12. Hautmanifestationen einer chronisch lymphatischen Leukämie sind häufig mit einer nicht-hämatologischen Hauterkrankung assoziiert
13. Two cases of quinine‐induced fixed ‘drug’ eruption induced by long drinks
14. Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma
15. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study
16. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study
17. Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network
18. Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
19. Role of B-cells in Mycosis Fungoides
20. Lebensqualiätätsanalyse bei Patienten mit primär kutanen Tund B-Zell-Lymphomen: FV-116
21. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
22. 样肉芽肿和 Sézary 综合征患者生活质量研究
23. A study of quality of life in people with mycosis fungoides and Sézary syndrome
24. Dysregulated Expression of Antimicrobial Peptides in Skin Lesions of Patients with Cutaneous T-cell Lymphoma
25. Associated primary tumours in patients with primary cutaneous lymphoma: a single‐centre retrospective cohort study
26. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study
27. T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients
28. Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides
29. Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides
30. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study
31. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark
32. T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients
33. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study
34. Low-dose gemcitabine therapy in CTCL: ‘real-life” data of the German Cutaneous Lymphoma Network
35. A diagnostic two gene classifier in patients with mycosis fungoides: a retrospective multicenter study
36. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
37. Skin involvement by chronic lymphocytic leukaemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression
38. 542 Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides
39. 480 Atopic dermatitis is an IL-13/IL10 driven disease with high molecular heterogeneity compared to psoriasis
40. 403 Comparative approach to assess the genetic background of inflammation in atopic dermatitis and psoriasis
41. Therapie seltener kutaner T‑Zell-Lymphome und der blastären plasmazytoiden dendritischen Zellneoplasie
42. 437 Integrated molecular and morphological characterization of psoriasis skin provides insights into disease mechanisms
43. Associated primary tumours in patients with primary cutaneous lymphoma: a single‐centre retrospective cohort study.
44. Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma.
45. Skin involvement by chronic lymphocytic leukaemia is frequently associated with unrelated neoplastic or inflammatory cutaneous disease and is not indicative of general disease progression.
46. Ther-O-04 - Dimethyl fumarate (DMF) therapy in CTCL: final results from a clinical phase II study.
47. QoL-O-01 - Update on the development of EORTC/CLTF questionnaires to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I.
48. BioIns-O-01 - Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study.
49. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients
50. Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.